Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LYNDSEY A HALE

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1417241670
CMS profile
199720
Location
SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$970.21

30 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $820.21 29
Consulting Fee $150.00 1

By paying entity

PY2021 · entire year · sorted by reported total

Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LYNDSEY A HALE

NPI 1417241670 · CMS profile ID 199720

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1417241670?year=2021&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LYNDSEY A HALE, NPI 1417241670, CMS profile ID 199720. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1417241670?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). LYNDSEY A HALE, NPI 1417241670, CMS profile ID 199720. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1417241670?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
LYNDSEY A HALE, NPI 1417241670, CMS profile ID 199720, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–30 of 30 matching records. This page contains 30 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1417241670?year=2021&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

30 matching records · $970.21 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 30 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–30 of 30.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Biohaven Pharmaceuticals, Inc. $7.8112/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852508059 CMS
EMD Serono, Inc. $2.7410/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849214591 CMS
EMD Serono, Inc. $23.4610/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849217825 CMS
Janssen Pharmaceuticals, Inc $14.9509/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788212177 CMS
Biohaven Pharmaceuticals, Inc. $5.3609/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852508055 CMS
Biogen, Inc. $24.3709/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 831276127 CMS
Lundbeck LLC $18.3309/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845910647 CMS
Novartis Pharmaceuticals Corporation $21.7009/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812707509 CMS
EMD Serono, Inc. $10.6208/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849209927 CMS
UCB, Inc. $23.1908/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807421091 CMS
Lilly USA, LLC $13.0708/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818637357 CMS
Biogen, Inc. $15.4308/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 831276119 CMS
Lundbeck LLC $123.7908/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845910645 CMS
Biohaven Pharmaceuticals, Inc. $6.2307/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852508051 CMS
Biohaven Pharmaceuticals, Inc. $124.5807/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852508047 CMS
EMD Serono, Inc. $0.7707/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849203449 CMS
EMD Serono, Inc. $10.7907/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849203453 CMS
Lundbeck LLC $20.9907/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845910643 CMS
UCB, Inc. $13.6007/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807374053 CMS
Biogen, Inc. $150.0007/07/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 831276131 CMS
Biohaven Pharmaceuticals, Inc. $12.4807/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852508043 CMS
EMD Serono, Inc. $118.0606/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849178613 CMS
EMD Serono, Inc. $11.0706/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849195879 CMS
ACADIA Pharmaceuticals Inc $15.6606/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838000783 CMS
Biogen, Inc. $16.3806/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 831276123 CMS
Biohaven Pharmaceuticals, Inc. $6.2105/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852508039 CMS
Lilly USA, LLC $11.4005/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818584815 CMS
Biogen, Inc. $116.5704/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 831276115 CMS
EMD Serono, Inc. $10.1504/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849176087 CMS
Adamas Pharmaceuticals, Inc. $20.4504/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834398645 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,683.21 82
PY2020 $304.43 17
PY2021 $970.21 30
PY2022 $177.32 5
PY2023 $668.84 7
PY2024 $2,387.24 26
PY2025 $8,757.36 37

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $33,613.25 12

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

12 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 GENZYME CORPORATION $10,482.05 11/17/2025 Non-covered Recipient Entity
University Of Texas At San Antonio
Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis No dispute reported 06/30/2026 1226132995
Principal investigator 1 Roche Products Limited $272.00 09/25/2025 Non-covered Recipient Entity
THE UNIV OF TEXAS HEALTH SCIENCE CTR AT
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211669265
Principal investigator 1 Roche Products Limited $272.00 09/25/2025 Non-covered Recipient Entity
THE UNIV OF TEXAS HEALTH SCIENCE CTR AT
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211669268
Principal investigator 1 Roche Products Limited $27.20 09/25/2025 Non-covered Recipient Entity
THE UNIV OF TEXAS HEALTH SCIENCE CTR AT
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211669272
Principal investigator 1 GENZYME CORPORATION $2,300.00 09/08/2025 Non-covered Recipient Entity
University Of Texas At San Antonio
Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis No dispute reported 06/30/2026 1226132987
Principal investigator 1 Roche Products Limited $272.00 06/25/2025 Non-covered Recipient Entity
THE UNIV OF TEXAS HEALTH SCIENCE CTR AT
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211669244
Principal investigator 1 Roche Products Limited $272.00 06/25/2025 Non-covered Recipient Entity
THE UNIV OF TEXAS HEALTH SCIENCE CTR AT
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211669248
Principal investigator 1 Roche Products Limited $272.00 06/25/2025 Non-covered Recipient Entity
THE UNIV OF TEXAS HEALTH SCIENCE CTR AT
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211669252
Principal investigator 1 Roche Products Limited $272.00 06/25/2025 Non-covered Recipient Entity
THE UNIV OF TEXAS HEALTH SCIENCE CTR AT
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211669254
Principal investigator 1 Roche Products Limited $272.00 06/25/2025 Non-covered Recipient Entity
THE UNIV OF TEXAS HEALTH SCIENCE CTR AT
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211669259
Principal investigator 1 Roche Products Limited $272.00 06/25/2025 Non-covered Recipient Entity
THE UNIV OF TEXAS HEALTH SCIENCE CTR AT
Observational Study of Ocrelizumab treated Multiple Sclerosis Patients US commitment No dispute reported 06/30/2026 1211669262
Principal investigator 1 GENZYME CORPORATION $18,628.00 04/21/2025 Non-covered Recipient Entity
University Of Texas At San Antonio
Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis No dispute reported 06/30/2026 1226132984